PRKAA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.666400E-01
Normal-vs-Stage2
6.800400E-01
Normal-vs-Stage3
6.883600E-02
Normal-vs-Stage4
4.745800E-01
Stage1-vs-Stage2
9.486800E-01
Stage1-vs-Stage3
2.226200E-01
Stage1-vs-Stage4
6.355200E-01
Stage2-vs-Stage3
1.089570E-01
Stage2-vs-Stage4
4.948200E-01
Stage3-vs-Stage4
1.722190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.870800E-01
Normal-vs-AfricanAmerican
3.294800E-01
Normal-vs-Asian
4.880400E-01
Caucasian-vs-AfricanAmerican
2.486400E-01
Caucasian-vs-Asian
2.117600E-01
AfricanAmerican-vs-Asian
5.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.361600E-01
Normal-vs-Female
7.186600E-01
Male-vs-Female
7.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.543200E-01
Normal-vs-Age(41-60Yrs)
5.777000E-01
Normal-vs-Age(61-80Yrs)
7.595600E-01
Normal-vs-Age(81-100Yrs)
6.003200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.606400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.610000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.481600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.178000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.150000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.049030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.504400E-01
Normal-vs-Daily Drinker
6.519200E-01
Normal-vs-Weekly Drinker
9.832600E-01
Normal-vs-Occasional Drinker
6.773200E-01
Normal-vs-Social Drinker
4.345000E-01
Non Drinker-vs-Daily Drinker
3.582800E-01
Non Drinker-vs-Weekly Drinker
8.798800E-01
Non Drinker-vs-Occasional Drinker
4.190600E-01
Non Drinker-vs-Social Drinker
1.275200E-01
Daily Drinker-vs-Weekly Drinker
5.416200E-01
Daily Drinker-vs-Occasional Drinker
1.342350E-01
Daily Drinker-vs-Social Drinker
4.265500E-02
Weekly Drinker-vs-Occasional Drinker
4.459000E-01
Weekly Drinker-vs-Social Drinker
1.422150E-01
Occasional Drinker-vs-Social Drinker
3.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.67469999990244E-07
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.53590473672693E-11
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.720200E-01
Grade 1-vs-Grade 3
4.358000E-01
Grade 1-vs-Grade 4
5.67469999990244E-07
Grade 2-vs-Grade 3
6.289000E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.53590473672693E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.517400E-01
Normal-vs-NonDiabetic
8.205000E-01
Diabetic-vs-NonDiabetic
6.433200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.897600E-01
Normal-vs-NoPancreatitis
9.660400E-01
Pancreatitis-vs-NoPancreatitis
3.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.766800E-01
Normal-vs-N1
7.322200E-01
N0-vs-N1
7.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.855190E-01
Normal-vs-TP53-NonMutant
7.882200E-01
TP53-Mutant-vs-TP53-NonMutant
3.392600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
